Molecular Breast Imaging

The future of Molecular Breast Imaging is low dose and 3D

Breast cancer represents 12% of new cancer cases and 25% of all cancers in women. Mammography is the most common modality used for breast imaging. Between 25% and 50% of women (depending on country and ethnic origins) have dense breast tissue, which limits mammography sensitivity.

Molecular Breast Imaging (MBI) is a test that uses a radioactive tracer and special cameras to find breast cancer. Rather than taking a picture of the breast, MBI is a type of functional imaging, meaning that the picture created shows difference in the activity of tissue.

Stay up to date with Kromek news

Subscribe to our newsletter

Unsure what product you need?

Use our Product Finder tool